DES(1-3) IGF-1: mechanism and evidence base DES(1-3) IGF-1 (also written Des(1-3)-IGF-1 or simply Des-IGF-1) is a truncated form of IGF-1 from which the first three N-terminal amino acids glutamic acid, proline, and threonine are removed
Identifying personal barriers, socioeconomic factors, education, and self-efficacy to improve disease risk and weight loss are crucial to the long-term success and benefits these medications provide
Often a good option for older patients with cardiac, pulmonary, or surgical-risk concerns
Anabolic Steroid Withdrawal Dependence and withdrawal are two phenomena commonly associated with drugs of abuse (Hochberg et al, 2003)
Research is currently underway to see if taking oral weight-loss medication (such as bupropion-naltrexone) can help ease the transition off GLP-1 receptor agonists and reduce the amount of weight that's typically regained after stopping them